These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15755968)

  • 1. Circulating and disseminated tumor cells.
    Braun S; Naume B
    J Clin Oncol; 2005 Mar; 23(8):1623-6. PubMed ID: 15755968
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients.
    Becker S; Solomayer E; Becker-Pergola G; Wallwiener D; Fehm T
    Breast Cancer Res Treat; 2007 Dec; 106(2):239-43. PubMed ID: 17260094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated tumor cells: the method is the message.
    Park JW
    Breast Cancer Res Treat; 2011 Feb; 125(3):739-40. PubMed ID: 20700647
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status in human breast cancer micrometastasis.
    Alix-Panabières C; Müller V; Pantel K
    Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity.
    Müller V; Stahmann N; Riethdorf S; Rau T; Zabel T; Goetz A; Jänicke F; Pantel K
    Clin Cancer Res; 2005 May; 11(10):3678-85. PubMed ID: 15897564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longtime recirculating tumor cells in breast cancer patients.
    Pachmann K
    Clin Cancer Res; 2005 Aug; 11(15):5657; author reply 5657-8. PubMed ID: 16061886
    [No Abstract]   [Full Text] [Related]  

  • 7. NCI launches an innovative design for a breast cancer clinical trial.
    Whitworth A
    J Natl Cancer Inst; 2006 Sep; 98(17):1178-9. PubMed ID: 16954467
    [No Abstract]   [Full Text] [Related]  

  • 8. Micrometastatic disease in breast cancer: clinical implications.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Eur J Cancer; 2008 Dec; 44(18):2726-36. PubMed ID: 19056036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Lang JE; Hall CS; Singh B; Lucci A
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 as marker for the detection of circulating tumor cells.
    Müller V; Pantel K
    Breast Cancer Res Treat; 2009 Oct; 117(3):535-7. PubMed ID: 19115105
    [No Abstract]   [Full Text] [Related]  

  • 11. Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells.
    Silva HC; Garcao F; Coutinho EC; De Oliveira CF; Regateiro FJ
    Neoplasma; 2006; 53(6):538-43. PubMed ID: 17167725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring circulating tumor cells as a surrogate end point for adjuvant therapy of breast cancer: what do they mean and what should we do about them?
    Bear HD
    J Clin Oncol; 2008 Mar; 26(8):1195-7. PubMed ID: 18323543
    [No Abstract]   [Full Text] [Related]  

  • 13. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells in breast cancer: fiction or reality?
    Cristofanilli M; Reuben J; Uhr J
    J Clin Oncol; 2008 Jul; 26(21):3656-7; author reply 3657-8. PubMed ID: 18640950
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
    Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
    Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.
    Mostert B; Sleijfer S; Foekens JA; Gratama JW
    Cancer Treat Rev; 2009 Aug; 35(5):463-74. PubMed ID: 19410375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of circulating tumor cells.
    Pantel K; Alix-Panabières C
    Nat Clin Pract Oncol; 2007 Feb; 4(2):62-3. PubMed ID: 17259923
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical significance of disseminated tumor cells in breast cancer.
    Slade MJ; Coombes RC
    Nat Clin Pract Oncol; 2007 Jan; 4(1):30-41. PubMed ID: 17183354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of catumaxomab on tumor cells in bone marrow and blood in ovarian cancer.
    Wimberger P; Heubner M; Lindhofer H; Jäger M; Kimmig R; Kasimir-Bauer S
    Anticancer Res; 2009 May; 29(5):1787-91. PubMed ID: 19443405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.